Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2026-02-21 @ 9:25 PM
Study NCT ID:
NCT01536067
Status:
TERMINATED
Last Update Posted:
2016-06-10
First Post:
2012-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia
Sponsor:
Roswell Park Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2014-04
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2012-02-10
First Submit QC Date:
None
Study First Post Date:
2012-02-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-03
Results First Submit QC Date:
None
Results First Post Date:
2016-06-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-05-03
Last Update Post Date:
2016-06-10
Last Update Post Date Type:
ESTIMATED